1990•Journal of NeuroimmunologyRequires access

On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy

Pieter A. van Doorn, F Rossi, Anneke Brand, M. van Lint, M. Vermeulen, M KAZATCHKINE

Open publisher page 93 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 93 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Chronic inflammatory demyelinating polyneuropathy, Medicine, Antibody, Guillain-Barre syndrome, Intravenous Immunoglobulins, Immunology, Polyneuropathy, Population

Back to paper search Browse research topics Original source

On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy — Research Paper | ScholarLens